This meeting will focus on the intersection between basic aging mechanisms and their effect on skeletal muscle disease. Molecular mechanisms discussed will include mTORC1 signaling, DNA damage & repair, aging-induced […]
External events
2025 SciFam Conference: Registration open
Registration is now open for SciFam, a four-day, in-person event for stakeholders in congenital muscular dystrophy, nemaline myopathy, and titinopathy. 2025 SciFam will take place August 1-5 in Philadelphia USA […]
Unlocking the Future of Rare Diseases: TREAT-NMD at World Orphan Drug Congress USA 2024
TREAT-NMD is honoured to be a media partner for this years World Orphan Drug Congress USA 2024 being held at the Boston Convention & Exhibition Centre from April 23 to April 25, 2024.
TREAT-NMD Joins the 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome
TREAT-NMD will be attending the Parent Project aps 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome. CEO, David Allison, and Neil Bennett, Head of Real World Evidence will be discussing the PaLaDIn project, and ‘The Interactium’ an innovative platform for data collection.
CureDuchenne Announces Educational Events for Families and Caregivers of Individuals with Duchenne or Becker Muscular Dystrophy
CureDuchenne has announced its schedule of CureDuchenne Cares workshops and dinner sessions for the first half of 2024, as well as its annual conference.
TREAT-NMD goes to Florida!
TREAT-NMD are very excited to be attending the 2024 MDA Clinical & Scientific Conference in March in Orlando, Florida. Following our successful partnership at the 2023 event, we are delighted to announce that we will be partnering with MDA alongside the FSHD Society on the ‘Clinical Considerations’ track with a dedicated session focused on therapeutics for FSHD.
